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Multi-component hybrid hydrogels –
understanding the extent of orthogonal assembly
and its impact on controlled release†
Vaˆnia M. P. Vieira, Laura L. Hay and David K. Smith *
This paper reports self-assembled multi-component hybrid hydrogels including a range of nanoscale
systems and characterizes the extent to which each component maintains its own unique functionality,
demonstrating that multi-functionality can be achieved by simply mixing carefully-chosen constituents.
Speciﬁcally, the individual components are: (i) pH-activated low-molecular-weight gelator (LMWG)
1,3;2,4-dibenzylidenesorbitol-40,400-dicarboxylic acid (DBS–COOH), (ii) thermally-activated polymer
gelator (PG) agarose, (iii) anionic biopolymer heparin, and (iv) cationic self-assembled multivalent (SAMul)
micelles capable of binding heparin. The LMWG still self-assembles in the presence of PG agarose, is
slightly modiﬁed on the nanoscale by heparin, but is totally disrupted by the micelles. However, if the
SAMul micelles are bound to heparin, DBS–COOH self-assembly is largely unaﬀected. The LMWG
endows hybrid materials with pH-responsive behavior, while the PG provides mechanical robustness.
The rate of heparin release can be controlled through network density and composition, with the LMWG
and PG behaving diﬀerently in this regard, while the presence of the heparin binder completely inhibits
heparin release through complexation. This study demonstrates that a multi-component approach can
yield exquisite control over self-assembled materials. We reason that controlling orthogonality in such
systems will underpin further development of controlled release systems with biomedical applications.
Introduction
Supramolecular hydrogels have emerged as a class of so
material with wide-ranging uses in high-tech applications –
from drug delivery and tissue engineering to environmental
remediation and nanoscale electronics.1 One way of increasing
the functionality of gels is to employ a multi-component
approach.2 There has been increasing interest in systems
where diﬀerent units self-sort – for example, gelators pro-
grammed with diﬀerent recognition pathways or which
assemble in the presence of diﬀerent stimuli into their own
independent nanoscale networks in the presence of one
another.3 Orthogonal assembly of diﬀerent types of nanoscale
component can also be achieved – for example gel nanobres
can assemble in the presence of vesicles and other self-
assembled nanostructures.4 Hybrid hydrogels can combine
the benecial properties of responsive supramolecular gels
formed by self-assembling low-molecular-weight gelators
(LMWGs) with robust polymer gels formed from assembly,
entanglement or crosslinking of polymer gelators (PGs).5
Hydrogels are of particular interest as a consequence of their
ability to encapsulate and deliver bioactive molecules, with
many reports of PGs used for drug delivery,6 and an increasing
number in which LMWGs and other supramolecular materials
are used.7 Heparin, which has clinical use as an anti-coagulant,8
has been incorporated in a number of polymer and silica gels
for controlled release, with release rate depending on network
density/swelling, interactions between heparin and the gel, or
a combination of both.9 There is interest in applying these for
transdermal or subcutaneous low-dose heparin delivery for long
term use in hospital settings.10 Heparin has also been included
in gels with potential applications in tissue engineering, to
control growth factor release and/or encourage tissue growth.11
However, supramolecular gels which incorporate heparin
remain very rare, and are restricted to gels based on relatively
complex self-assembling peptides.12 We decided to incorporate
heparin in gels based on simple, commercially-relevant
LMWGs, and employ a multi-component approach to yield
multi-functional materials, which combine the activities of
multiple diﬀerent units within a single gel. The design of our
system (Fig. 1) included:
1. Low molecular weight gelator (LMWG): DBS–COOH
This is a self-assembling pH-responsive gelator developed in
our laboratory,13 based on an industrially-relevant 1,3;2,4-
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dibenzylidenesorbitol (DBS) framework14 modied with
carboxylic acids on the aromatic ‘wings’.
2. Polymer gelator (PG): agarose
This saccharide biopolymer has good biocompatibility forming
a robust, stable hydrogel through a nanobrillar mechanism.20
3. Bioactive polymer: heparin
This is biomedically-relevant with applications ranging from
coagulation control15 to angiogenesis in transplanted cell
cultures.16
4. Heparin binding micelles: C16-DAPMA
Cationic lipids act as nanoscale self-assembled multivalent
(SAMul) heparin binders.17 We selected C16-DAPMA, which
forms spherical micelles (diameter ¼ 6.2 nm), and is an eﬀec-
tive heparin binder.18 We previously reported full characteriza-
tion of the hierarchical self-assembled nanostructures which
form when cationic C16-DAPMA micelles bind anionic
heparin.19
Components 1 and 4 rely on self-assembly to reversibly form
nanostructures, while components 2 and 3 are polymeric. The
aim of this study was to characterize and fully understand
multi-component systems derived from these units, deter-
mining the precise inuence of each component on the others,
and probing the ability to release heparin. Gel characterization
is a challenging task, performed across multiple length scales –
from molecular-scale to nanoscale to macro-scale,21 made more
complex when multiple components are present. This study
provides fundamental insights into complex multi-component
self-assembled so materials, and the extent to which the
individual components can be considered to be orthogonal.
Results and discussion
Synthesis and characterization of components
LMWG DBS–COOH was synthesised on multi-gram scale
according to our previously reported simple methodology.13
DBS–COOH forms gels by slow acidication induced by hydro-
lysis of glucono-d-lactone (GdL)22 or by UV-initiated photo-
activation with diphenyliodonium nitrate.23 On this occasion,
we employed GdL as a gelation trigger – this compound could,
of course, be considered as an additional h component in
our multicomponent approach, but as it is molecular-scale
rather than nanoscale, we do not focus on it as such. The
thermally-stable gels formed by DBS–COOH (Tgel > 100
C) were
fully consistent with previous reports.13 C16-DAPMA was also
synthesised using well-established, high yielding methods
employing protecting group and amide coupling method-
ology.18 The heparin binding characteristics of C16-DAPMA
were in-line with previous reports.18,19
DBS–COOH + heparin
Initially, we aimed to understand the impact of polyanionic
heparin on the self-assembly of DBS–COOH (0.2% wt/vol,
4.5 mM). We selected 38–500 mM heparin as representing
meaningful concentrations.24 In all cases, macroscopic gelation
was observed (Fig. S1†), and Tgel values were above the solvent
boiling point (>100 C). This indicates that heparin does not
prevent DBS–COOH self-assembly. However, we wanted to
determine if heparin aﬀected LMWG assembly in subtler ways.
The IR spectrum of the xerogel formed by DBS–COOH
(0.2% wt/vol) and heparin (300 mM) basically corresponded to
overlap of the separate IR spectra of DBS–COOH and heparin
(Fig. S3–S6†). This would suggest that specic interactions
between components are limited (or at least cannot be observed
by IR).
1H NMR was used to investigate gelation kinetics. On
pH-induced self-assembly of DBS–COOH, resonances associ-
ated with the mobile solution-phase gelator molecules disap-
pear. Use of an internal standard allows this to be quantied.25
This experiment was performed using DBS–COOH (0.2% wt/vol)
in the absence and presence of heparin (300 mM) – in both
cases, results were essentially the same (Fig. S7†). For the rst
hour, although pH was changing no gel was formed, but aer
this, gel formation began, resonances associated with the
gelator decreased in intensity, and self-assembly progressed
over the following 7 hours until macroscopic gelation was
complete.
Circular dichroism (CD) spectroscopy was similarly used to
characterize assembly kinetics. However, this experiment was
performed at a signicantly lower concentration (0.02% wt/vol),
below theminimum gelation concentration (MGC). Under these
conditions, DBS–COOH nanobers assemble, but do not
entangle to form a macroscopic sample-spanning network, and
hence gelation is not observed.13a Nanobre self-assembly can
be inferred from the signicant increase in CD band intensity –
indeed, deprotonated DBS–COO has no CD band, whereas
once the molecule becomes protonated, the CD band at 260 nm
Fig. 1 Components incorporated into the multi-component hybrid
hydrogels investigated in this paper.
Chem. Sci. This journal is © The Royal Society of Chemistry 2017
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becomes very signicant, consistent with p–p stacking of the
aromatic rings into a nanoscale chiral environment (Fig. S8 and
S9†).21 In this way, self-assembly kinetics can be followed, and
the nal CD spectrum gives direct insight into the nanoscale
chirality of the self-assembled bres. On self-assembly, DBS–
COOH (0.02% wt/vol) developed a CD band at ca. 259 nm. A very
similar band also appeared for DBS–COOH (0.02%wt/vol) in the
presence of heparin (38 mM) indicating a similar mode of
assembly. However, plotting the intensity of this band against
time (Fig. 2) revealed that in the presence of heparin, the
assembly of nanobers is faster, and assembly starts sooner.
Furthermore, in the presence of heparin, the nal CD band was
larger than that observed for DBS–COOH alone, suggesting that
the nanoscale chirality of the resulting assembly is somewhat
modied. This experiment therefore suggests that heparin can
assist LMWG self-assembly at the nanoscale andmay give rise to
nanoscale objects with diﬀerent chiralities/morphologies.
To gain greater insight into the self-assembled nanoscale
morphologies, transmission electron microscopy (TEM) of the
dried hydrogels (0.2% wt/vol) was performed. TEM images of
DBS–COOH (Fig. 3, top) indicated intertwined long and twisted
nanobres. When heparin (38 mM) was also present (Fig. 3,
bottom), long nanobres were once again observed, but it was
also possible to distinguish some diﬀerentiated structures,
particularly on the tips of the nanobres (see also Fig. S12 and
S13†). We reason these are associated with or caused by the
heparin – we suggest that non-specic adsorption of heparin
onto the growing nanobres modies the morphology and gives
rise to the enhanced assembly kinetics observed by CD – indeed,
related eﬀects have previously been described for soluble poly-
mers added to gels.26 Interestingly, it is well-known that heparin
can assist bril assembly in biological peptides such as
amyloids.27 Our observations here suggest heparin can also
impact on simple LMWG self-assembling systems. Nonetheless,
overall, TEM imaging supports the view that DBS–COOH self-
assembly does still occur in the presence of heparin –
although is somewhat modied in terms of nanoscale
morphology.
Scanning electron microscopy (SEM) was performed on
samples prepared via freeze-drying to minimise morphological
change on drying. DBS–COOH (Fig. 4, top) exhibited an
expanded nanobre mesh, with bre diameters of ca. 80 nm – in
good agreement with TEM. In the presence of heparin (Fig. 4,
bottom) nanobres were also formed, but were signicantly
narrower – ca. 50 nm. These smaller bres suggest enhanced
nucleation of gel nanobers induced by heparin. In such
a model, more bres form, but can then only grow to smaller
diameters. This is in agreement with time-resolved CD, which
indicated enhanced nanoscale assembly kinetics, supporting
the view that heparin interacts with DBS–COOH nanobres in
the growth phase and hence somewhat modies nanoscale
morphology.
For macroscopic characterisation, rheology was performed
on DBS–COOH (0.2% wt/vol) alone and in the presence of
heparin (1 mM). This technique provides storage (elastic)
modulus (G0) and loss (viscous) modulus (G00) through applica-
tion of oscillating strains. As ‘solid-like’ materials, gels exhibit
G0 values ca. one order of magnitude higher than G00 and low
frequency dependence. We initially monitored strain amplitude
dependence to characterize the linear viscoelastic region (LVR)
over which gel-like properties persist (Fig. S17†). For DBS–
COOH, gel-like behaviour was observed up to ca. 3% strain.
Similar behaviour was observed in the presence of heparin.
Fig. 2 CD intensity at 255 nm plotted against time for DBS–COOH
(0.02% wt/vol) in the absence and presence of heparin (38 mM).
Fig. 3 (Top) TEM image of DBS–COOH gel (0.2% wt/vol). Scale bar:
1 mM. (Bottom) TEM image of DBS–COOH gel (0.2% wt/vol) in the
presence of heparin (38 mM). Scale bar: 200 nm.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci.
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However, G0 and G00 values were 3-fold lower in the presence of
heparin – i.e., heparin makes the network less stiﬀ. This agrees
with TEM/SEM imaging of a modied nanoscale morphology,
with thinner nanobres leading to a less-stiﬀ network on the
macroscopic scale. Monitoring response to frequency led to
similar conclusions (Fig. S18†) – we note that frequency was
increased to high values (ca. 100 Hz) and this leads to an
increase in G0 and G00, indicative of hardening being induced by
high frequencies at which gel dynamics are being studied over
very short timescales – similar eﬀects have previously been re-
ported.28 We also characterised the 2% wt/vol DBS–COOH gel
(Fig. S19 and S20†) – this system was signicantly stiﬀer (G0 ¼
ca. 110 000 Pa in the LVR) compared with the 0.2% wt/vol gel
(G0 ¼ ca. 2600 Pa in the LVR). As might be expected these stiﬀer
2% wt/vol gels were less resistant to strain, and broke down at
ca. 1% strain rather than ca. 3%.
We nally explored the ability of these gels to release heparin
into buﬀered water. Heparin release was probed by placing
buﬀer (10 mM Tris–HCl, 150 mM NaCl, pH 7.4, 1 mL) on top of
the hydrogel (3 mL) incorporating heparin (1 mM). Aliquots of
buﬀer were removed over time, added into Mallard Blue (MalB)
solution and the UV-Vis absorbance measured. MalB is
a heparin sensor29 and therefore enables the quantication of
heparin release via UV-Vis spectroscopy. Fig. 5 shows release of
heparin (1 mM) from DBS–COOH (0.2% wt/vol and 2% wt/vol).
At 0.2% wt/vol gelator loading, there is relatively rapid initial
heparin release, rising to ca. 40% over the rst 6 hours. There is
then slower release, with a further 40–45% being released over
the ensuing 42 hours, giving a total of ca. 85% release. At 2%
wt/vol gelator loading, the initial rapid release over the rst
6 hours still occurs, up to a total of ca. 40%, but aer this, no
further heparin is released. We also investigated gelator load-
ings of 5% and 10% wt/vol – these behaved identically to the
2% wt/vol gel (Fig. S27†).
These results suggest the gel nanobre network plays an
active role in controlling heparin release. Heparin is a relatively
large biopolymer, and will have limited diﬀusion within a gel
matrix. As the loading of gelator is increased, and rheological
stiﬀness signicantly increases (see above), the ability of the
heparin to diﬀuse within the gel decreases. We propose that
$2% wt/vol, only the heparin initially close to the gel surface
can be released – ca. 30–40%. Heparin further away from the
interface is incapable of diﬀusing to the interface, and is not
released – further evidence for this hypothesis is presented
below once agarose is also incorporated into the system. At
0.2% wt/vol loading, there is still initial rapid release of ca. 40%
of the heparin, but the lower density nanober network then
allows for some diﬀusion of heparin, which is slowly released
over time. Alternatively, as suggested by a reviewer, it is plau-
sible that at lower loadings, the DBS–CO2H gel is more easily
damaged by the presence of buﬀer solution on top, enabling
enhanced slow release – but we emphasise that in no case was
any visible damage to the gel surface observed, and gel integrity
was always tested by tube inversion at the end of the heparin
release experiment. In summary, these gels can release heparin,
with release rate and total amount released depending on
LMWG loading.
We conclude that DBS–COOH and heparin are largely
orthogonal. DBS–COOH gels still form in the presence of
heparin, have good thermal stability, and macroscopic gelation
Fig. 4 (Top) SEM image of DBS–COOH gel (0.2% wt/vol). (Bottom)
SEM images of DBS–COOH gel (0.2% wt/vol) in the presence of
heparin (38 mM). Scale bars: 1 mm.
Fig. 5 Heparin release from 0.2% w/v ( ) and 2% w/v ( ) of DBS–
COOH hydrogels with 1 mM of heparin.
Chem. Sci. This journal is © The Royal Society of Chemistry 2017
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kinetics are similar. However, there are subtle diﬀerences in
nanoscale assembly kinetics (see CD). TEM and SEM indicate
that the nanobers formed by DBS–COOH are narrower when
heparin is present, suggesting they nucleate more quickly,
promoted by heparin. This has an impact on macroscopic gel
performance – in the presence of heparin, the gel maintains
resistance to strain, but is less stiﬀ. Heparin release can be
achieved, but there is a threshold DBS–COOH network density
that prevents heparin diﬀusion, limiting total release. In this
way, release kinetics are controlled by network density. In
summary, these two components clearly tolerate one another
when incorporated in a multi-component system.
DBS–COOH + C16-DAPMA
We then studied the combination of DBS–COOH and cationic
lipid C16-DAPMA, which self-assembles into multivalent
micelles. We tested the eﬀect of C16-DAPMA (150 mM to 1 mM)
on the gelation of DBS–COOH (0.2% wt/vol). In no case was
gelation observed (Fig. S2†) – C16-DAPMA completely inhibits
gelation of DBS–COOH. Either the amines on C16-DAPMA
buﬀer the solution and limit protonation of DBS–COOH,
hence preventing gelation, or direct interactions between acidic
DBS–COOH and basic C16-DAPMA inhibit gel assembly. These
two components are clearly not orthogonal.
DBS–COOH + agarose
Inspired by the pioneering work of Yang and co-workers, who
combined agarose with a LMWG,30 we previously characterized
the combination of LMWG DBS–COOH and PG agarose,13
demonstrating it yields responsive but robust materials, in
which each component essentially maintained its own charac-
teristic behaviour. It is worth noting that the temperature at the
outset of this experiment is higher than when DBS–COOH is
studied in the absence of agarose, and that this may impact on
GdL hydrolysis rate and nanobre formation. NMR evidence
suggested little diﬀerence in the kinetics of gel assembly
although CD spectroscopy indicated small diﬀerences in
nanobre chirality.13
Going further than previously, we performed careful SEM
analysis of these gels (and their individual constituents) using
our freeze drying sample preparation method to yield expanded
xerogels, rather than collapsed ones. As described above,
DBS–COOH exhibited a nanobrillar morphology with bre
diameters of ca. 80 nm. As expected,20 agarose also formed
a nanobrillar gel, but with thinner bres of ca. 10 nm
(Fig. S14†). These narrower bres are consistent with the opti-
cally transparent nature of agarose while the larger bres of
DBS–COOH are in agreement with its slightly hazy nature.
Pleasingly, on imaging the hybrid gel (Fig. 6) both types of bre
appeared to be present – suggesting that the two networks do
indeed assemble independently of one another. Examples
where self-sorted gel nanobres can be clearly visualised in
multi-component gels remain relatively rare.31
We also performed additional rheological characterization
of the hybrid hydrogel. The addition of agarose (1% wt/vol) to
DBS–COOH (0.2% wt/vol) resulted in a signicant (ca. 3-fold)
increase in G0 from ca. 2600 Pa to ca. 7900 Pa (Fig. S21†). The
LVR remained the same, with the gel being able to resist up to
ca. 3% strain, and the frequency dependence also remained
similar (Fig. S22†). The impact of agarose on G0 shows that the
PG contributes to the formation of a stiﬀer gel, reinforcing the
relatively weak DBS–COOH network. Agarose alone behaves
similarly in terms of rheology to the hybrid gel in terms of G0,
although it breaks down at slightly lower strain (Fig. S23 and
S24†). This would indicate that the polymer gel is indeed
dominating the stiﬀness of the hybrid material, although the
soer, more exible self-assembled DBS–COOH LMWG
network may be enhancing resistance to strain.
As reported previously,13 NMR methods demonstrated that
addition of base to the hybrid gel deprotonated DBS–COOH,
leading to disassembly of its nanoscale network – i.e., the
LMWG retains its responsiveness in the presence of the PG.
In summary, these components are clearly orthogonal to one
another.
DBS–COOH + heparin + C16-DAPMA
We then studied the three-component combination in which
heparin and heparin binder (C16-DAPMA) are both present,
alongside the LMWG (DBS–COOH). Although DBS–COOH and
C16-DAPMA are a disruptive combination, we reasoned that
once the C16-DAPMA micelles are bound to heparin,
DBS–COOH may then self-assemble.
We tested the formation of DBS–COOH gels in which
a solution of C16-DAPMA and heparin was added to the sample
immediately before, or immediately aer, the addition of glu-
cono-d-lactone. The order of addition did not have any eﬀect. A
series of heparin concentrations were tested, and to each,
increasing concentrations of C16-DAPMA were added (Table 1).
This determined the maximum tolerance of the gel towards
C16-DAPMA when heparin is also present. For each
Fig. 6 SEM image of DBS–COOH gel (0.2% w/v) in the presence of
agarose (0.5% w/v). The two diﬀerent thicknesses of ﬁbre are labelled
with white arrows (narrower agarose ﬁbres) and black arrows (thicker
DBS–COOH ﬁbres). Scale bar: 100 nm.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci.
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concentration of heparin, there was a threshold concentration
of C16-DAPMA up to which gelation of DBS–COOH will still
occur – once the amount of C16-DAPMA exceeds that, then
gelation is disrupted (Table 1). For heparin concentrations of
38, 150, 300, 400 and 600 mM, the C16-DAPMA threshold
concentrations are 150, 450, 800, 900 and 1400 mM respectively.
As the amount of heparin increases, larger amounts of
C16-DAPMA can be added without disrupting the gel. We
reason (see below) that C16-DAPMA interacts with the heparin
in the gel and hence does not prevent DBS–COOH assembly.
Above the threshold concentration, excess C16-DAPMA causes
gel breakdown. All of the gels had thermal stabilities >100 C –
equivalent to DBS–COOH on its own.
Table 2 presents the maximum tolerated C16-DAPMA/
heparin molar and charge ratios.24 At low loadings in the gel,
heparin binds 4.0 molar equivalents of C16-DAPMA (a charge
ratio of 2.0). However, when more heparin is present in the gel,
it only binds 2.0–2.5 molar equivalents of C16-DAPMA (a charge
ratio of 1.0–1.25). C16-DAPMA forms spherical micelles with
a diameter of ca. 6.2 nm, while heparin is a linear polyanion.
Although heparin has some exibility and ‘adaptive’ char-
acter,32 it cannot fully wrap around these small micelles.19 At low
heparin concentration therefore, some of the ligands on the
micelle will be unsatised, and excess C16-DAPMA is required
to fully bind heparin. However, as the concentration of heparin
increases, the likelihood of multiple heparin chains contacting
a single micelle increases – under these conditions, many more
of the ligands will actively bind heparin, and the charge ratio of
the complex comes closer to 1.0. As such, we have a good
understanding of the complexation process between self-
assembled C16-DAPMA and heparin, which occurs with the
gel matrix. This is a unique study of self-assembly and binding
between nanoscale systems within a self-assembled nano-
brillar gel medium.
NMR studies of gelation kinetics in the three-component
system of DBS–COOH (0.2% wt/vol), heparin (300 mM) and
C16-DAPMA (800 mM) were very similar to those for DBS–COOH
alone and in the presence of just heparin (described above).
Gelation was eﬀectively complete aer 8–10 hours, with all of
the gelator becoming immobilised (Fig. S7†).
CD spectroscopy was used to study nanoscale bre assembly
kinetics in the three component system of DBS–COOH
(0.02% wt/vol), heparin (38 mM) and C16-DAPMA (150 mM). In
this case, the onset of assembly was delayed (Fig. S10 and S11†),
and once assembly was complete, a slightly diﬀerent CD signal,
with a longer wavelength peak (ca. 262 nm) was obtained. While
heparin alone accelerated DBS–COOH nucleation and nano-
bre assembly, heparin complexed to C16-DAPMA therefore
slows and somewhat modies chiral nanostructure assembly
(see below).
Fig. 7 (and Fig. S16†) presents a TEM image of DBS–COOH
(0.2% wt/vol) assembled in the presence of both heparin
(38 mM) and C16-DAPMA (150 mM). Typical hierarchical aggre-
gates between C16-DAPMA micelles and heparin as charac-
terised previously,19 along with nanobers of DBS–COOH were
observed. This is reminiscent of the work of van Esch and co-
workers visualising orthogonal assembly of gel nanobres and
vesicles.4a,b However, in our case, there are not just two, but
three components present. TEM shows gel nanobres, and also
that the other two components (self-assembled C16-DAPMA
micelles and heparin) are mutually interacting with one
another. There is some suggestion from the imaging (Fig. S16†)
that the presence of the hierarchical aggregates may somewhat
Table 1 Test of diﬀerent heparin/C16-DAPMA ratios in gel formation.
An unstable gel was not fully stable to inversion, a partial gel had only
part of the sample forming an eﬀective gel, a gel with aggregates had
some opaque aggregated material present. Stable gel is the desired
homogenous state in each case – the maximum concentrations at
which stable gels could form are highlighted in bold
[Heparin] (mM) [C16-DAPMA] (mM) Gel formation
38 $200 No gel formation
#150 Stable gel
150 600 No gel formation
500 Unstable gel
#450 Stable gel
300 $1000 No gel formation
900 Partial gel
#800 Stable gel
400 $1500 No gel formation
1400–1000 Gel with aggregates
#900 Stable gel
600 $2100 No gel formation
2000–1800 Unstable gel
1700–1500 Gel with aggregates
#1400 Stable gel
Table 2 Maximum C16-DAPMA/Heparin molar ratios and charge
ratios (+/) at increasing heparin concentrations
[Heparin]
(mM)
C16-DAPMA/heparin
molar ratio
Charge ratio
+/
38 4.0 : 1 2.0
150 3.0 : 1 1.5
300 2.7 : 1 1.3
400 2.2 : 1 1.1
600 2.3 : 1 1.2
Fig. 7 TEM image of DBS–COOH gel (0.2% w/v) in the presence of
heparin (38 mM) and C16-DAPMA (150 mM). Scale bar: 200 nm.
Chem. Sci. This journal is © The Royal Society of Chemistry 2017
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hinder/disrupt DBS–COOH nanobre assembly. TEM images
with higher concentrations of heparin (300 mM) and
C16-DAPMA (800 mM) were similar but with more hierarchical
assembly.
SEM of the DBS–COOH gel (0.2% wt/vol) incorporating both
heparin (38 mM) and C16-DAPMA (150 mM) only showed
DBS–COOH nanobers (Fig. S15†), conrming that standard
DBS–COOH nanobres are being formed (even though the bres
visualised by TEM in Fig. 7 appeared a little diﬀerent). It was not
possible to observe C16-DAPMA interacting with heparin by SEM
– so self-assembled micelles are diﬃcult to image using this
technique, indeed, we have never succeeded in any of our other
studies.17–19 Interestingly, the bres were more like the larger
bres formed in the absence of heparin than the narrower bres
formed in its presence, in agreement with the view that C16-
DAPMA binds heparin, hence preventing its interaction with
growing gel nanobers. SEM studies with higher concentrations
of heparin and C16-DAPMA gave similar results.
Rheology was performed on these three-component gels
(Fig. S17 and S18†). The gels broke down on application of 1%
strain (rather than 3% as for DBS–COOH or DBS–COOH with
heparin). Furthermore, the G0 value was lower than for DBS–
COOH alone (and a little lower than that for DBS–COOH with
heparin). As such, although SEM imaging indicated that the gel
nanobers can self-assemble intact with similar morphology to
DBS–COOH alone, clearly the presence of hierarchical aggre-
gates formed between heparin and C16-DAPMA weakens the
overall network on the macroscopic level. The hierarchical
aggregates are relatively large (>100 nm) and thus represent
points of weakness in the overall entangled gel network.
The ability of this three-component system to release
heparin was then investigated (Fig. S26†). Unlike the simple
mixture of DBS–COOH and heparin described above, no release
of heparin was observed over 72 hours. As a result of binding to
C16-DAPMA within the gel, heparin release is completely
inhibited – clearly proving that all three components are active
within this multi-component gel, programming it with their
individual characteristics, and hence controlling its
performance.
In summary, mixing both heparin and C16-DAPMA into
DBS–COOH leads to a largely orthogonal system in which
DBS–COOH and C16-DAPMA both self-assemble into their own
respective nanostructures, with heparin preventing the disrup-
tive eﬀect of C16-DAPMA by binding strongly to the micelles. On
the nanoscale, as monitored by CD and TEM, the assembly of
DBS–COOH is somewhat inhibited – we suggest this reects
greater diﬃculty in assembling nanobres as a result of steric
hindrance provided by the relatively large hierarchical
heparin:C16-DAPMA aggregates. This also ultimately somewhat
aﬀects the macroscopic rheological properties of the material.
The binding of C16-DAPMA to heparin completely inhibits its
release from the gels. This system can therefore be considered
a storage medium for bioactive heparin – only breakdown of the
gel, or degradation of the heparin binder would enable heparin
release. Importantly, each of the three components can full its
orthogonal role within this system, although they do have
subtle impacts on one another.
DBS–COOH + heparin + agarose
We then studied the impact of agarose on the gels formed by
DBS–COOH and heparin, in particular, their rheological
performance, as the PG should make these systems more
robust. As noted above, the addition of agarose (1% wt/vol) to
DBS–COOH (0.2% wt/vol) resulted in a signicant increase of G0
values from 2600 Pa to 7900 Pa. The addition of heparin (1 mM)
to this hybrid hydrogel had no impact on rheological perfor-
mance (Fig. S21 and S22†). Interestingly, this is in contrast to
the impact of heparin on DBS–COOH alone (see above) in which
G0 was lowered. Clearly, as noted above, the macroscopic
rheological stiﬀness of DBS–COOH/agarose hybrid hydrogels is
dominated by agarose, which is unaﬀected by the presence of
heparin.
Having demonstrated that agarose provides mechanical
robustness, the pH response of DBS–COOH was checked. A
hybrid gel of DBS–COOH (0.2% wt/vol) and agarose
(0.5% wt/vol) was prepared in an NMR tube in the presence of
heparin (1 mM) and GdL. Prior to gelation, NMR resonances
associated with mobile DBS–COOH were observed, which dis-
appeared as it is protonated and assembles into gel nanobers.
Basic aqueous NaOH was then added to the top of the gel and
allowed to diﬀuse in. NMR spectra were recorded periodically to
observe the re-appearance of the peaks associated with DBS–
COOHas the compound deprotonates and the LMWGnanobres
disassemble (Fig. 8). Throughout the experiment, the sample
remained as a gel, demonstrating that the agarose PG maintains
overall stability. Aer ca. 24 hours, the gel nanobers associated
with DBS–COOH are clearly disassembling, a process complete
aer ca. 5 days. Diﬀusion into the gel in this experiment is
limited by the narrow diameter of the NMR tube – in other
geometries, the stimulus could be applied more rapidly. Clearly,
heparin does not inhibit disassembly of the LMWG DBS–COOH
network. Such hybrid multi-component systems can therefore
have one of their two networks broken down – in this case, we
break down the network controlling heparin release – hence
leading to triggered heparin release induced by a pH change.
Heparin release was studied using hybrid hydrogels
prepared using DBS–COOH (2% wt/vol) and agarose (0.5% or
Fig. 8 NMR spectra of aromatic protons of DBS–CO2H (0.2% wt/vol),
agarose (0.5%wt/vol) and heparin (1 mM), (from bottom to top) prior to
gelation, after full gelation, and after various times (19.5 h, 26 h, 45 h
and 69 h) of exposure to NaOH.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci.
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1% wt/vol) and assayed with MalB as described previously. The
presence of 0.5 or 1% wt/vol of agarose had no inuence on
heparin release – the proles were identical to those for
DBS–COOH alone (Fig. S28†).
To understand the impact of agarose PG alone on heparin
release in more detail, we prepared gels at 1%, 2.5%, 5%, 7.5%
and 10% wt/vol agarose with 1 mM of heparin and assayed
heparin release. As agarose loading increases, heparin release
slows down (Fig. 9). On increasing PG loading, the gel network
will have smaller pores that will contribute to slower diﬀusion
and thus lower release – indeed release over 4 days fell from
>90% with 1% wt/vol agarose to only ca. 30% with 10% wt/vol
agarose. Importantly, 1% wt/vol agarose allows maximal
release of heparin, in agreement with the view that in the hybrid
system of DBS–COOH, agarose and heparin, characterized
above, DBS–COOH controls heparin release, while agarose
simply provides the multicomponent system with rheological
strength.
Interestingly, however, increasing the loading of agarose has
a progressive eﬀect on diﬀusion and release of heparin, while in
DBS–COOH there was a threshold value beyond which diﬀusion
appeared to stop completely. We propose that diﬀusion of
heparin in the two diﬀerent gels occurs via diﬀerent mecha-
nisms. We propose, based on all the evidence presented above,
that DBS–COOH has ‘sticky’ nanobers which interact with
heparin and at high enough density ($2% wt/vol) completely
limit diﬀusion. In contrast, for agarose, we propose the barrier
to heparin diﬀusion is purely steric, and heparin reptation
allows some diﬀusion/release, even at PG loadings as high as
10% wt/vol.
A key advantage of the greater mechanical robustness of
hybrid hydrogels endowed by agarose, is the ability to physically
manipulate the gels. We prepared 3D gel ‘cylinders’ (Fig. S29†)
containing DBS–COOH (2% wt/vol), agarose (1% wt/vol), and
heparin (17 mM) and placed them into a large volume of buﬀer.
Fig. 10 compares heparin release from these hybrid gel cylin-
ders against gels in vials. Using gel cylinders increases heparin
release from ca. 40% to ca. 80% release aer 3–4 days. By
decreasing the total volume of the gel, and exposing all surfaces
to the receiving buﬀer medium, the eﬀective surface
area : volume ratio of the gel increases ca. 6.5-fold (see ESI,
Section 1.10†). We suggest this enables more of the heparin to
be close to the surface and hence released. This supports our
view, expressed earlier in the paper, that release of heparin from
DBS–COOH is limited by the heparin encapsulated more deeply
within the volume of the gel being unable to diﬀuse to the
surface as a consequence of both network density and the
ability of heparin to interact with the ‘sticky’ DBS–COOH
nanobres. In addition to providing further insight into the
impact of DBS–COOH on heparin release, this experiment also
clearly demonstrates that the robust agarose PG enables phys-
ical formulation of these multi-component hydrogels.
Conclusions
We have used a simple multi-component approach to hybrid
hydrogels with two self-assembling components (DBS–COOH
and C16-DAPMA) and two polymeric components (heparin and
agarose) and carefully characterised the impact of each
component on the others. This is the rst time such a detailed
study has been performed in a multi-component gel of this
complexity.
The self-assembly of DBS–COOH is slightly modied on the
nanoscale by heparin, completely disrupted by C16-DAPMA and
unaﬀected by agarose. However, if the heparin is bound to self-
assembled multivalent C16-DAPMA, then the assembly of
DBS–COOH still takes place, and although the presence of the
hierarchical heparin/C16-DAPMA aggregates has some minor
impacts on gel performance, the components are largely
orthogonal to one another. The PG reinforces all materials when
present, and dominates macroscopic stiﬀness. DBS–COOH
retains its pH sensitivity and can be disassembled in the pres-
ence of the other components, hence introducing triggered
response characteristics to these hybrid hydrogels.
It is therefore possible to formulate hybrid hydrogels with
diﬀerent heparin release characteristics depending on:
 Loading of DBS–COOH – a threshold loading prevents
heparin release from the interior of the bulk gel as a result of an
interactive mechanism.
Fig. 9 Heparin release from 1.0% w/v (yellow), 2.5% w/v (blue),
5.0% w/v (orange), 7.5% w/v (green) and 10% w/v (purple) of agarose
gels with 1 mM of heparin.
Fig. 10 Diﬀerent methods of heparin release from DBS–COOH
hydrogel (2% w/v) and agarose (1% w/v) containing heparin. ( ): gel
cylinder. ( ): buﬀer on top of the gel.
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 Loading of agarose – higher agarose loadings decrease
heparin release kinetics due to steric hindrance to diﬀusion.
 Presence of C16-DAPMA – self-assembled multivalent C16-
DAPMA fully bound to heparin completely inhibits heparin
release.
 Gel shape – the ratio of surface area to internal volume
controls the amount of heparin released – larger relative surface
areas giving rise to greater release when interactive DBS–COOH
nanobers are present.
We have gained fundamental insight into multi-component
systems – this strategy is a powerful way of formulating multi-
functional materials and tuning desired characteristics for
bioactive release. In ongoing research, we are targeting trig-
gered heparin release under physiologically relevant conditions
and multi-component hybrid gels, which may ultimately have
biomedical applications.
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